Katarzyna Pasik

Dr. Katarzyna Pasik


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2014 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Open access
PDF file
MJMagdalena Jaszek
Magdalena Jaszek
KPKatarzyna Pasik
Katarzyna Pasik
AMAnna Matuszewska
Anna Matuszewska
MGMarcin Grąz
Marcin Grąz
DSDawid Stefaniuk
Dawid Stefaniuk
KGKrzysztof Grzywnowicz
Krzysztof Grzywnowicz
The effect of menadione (MQ; 2-methyl-1,4-naphtoquinone), a superoxide-generating agent, on the natural biodegradation system in the medicinal white rot fungus Phellinus pini was determined. While measuring the activities of extracellular manganese-dependent peroxidase (MnP) and intracellular chitinase, it was found that the application of MQ (0.75 mM) distinctly stimulated the activities of these enzymes in comparison to the control values (without MQ). Using the capillary electrophoresis (CE) method, an increase in the extracellular oxalic acid (OXA) concentration was detected during the first days after the addition of MQ. It was observed that the rate of intracellular proteolysis at pH 3.5 evidently decreased under oxidative stress conditions. Contrary to these results, the activities of serine proteases at pH 9.5 measured against fluorogenic peptide substrates distinctly increased in stressed cultures. The MQ treatment also caused an evident increase in the catalase (CAT) activity, as well as the levels of superoxide anion radicals (SORs), formaldehyde (FA), and phenolic compounds (PHC) in the experimental cultures. The results obtained confirm that prooxidants may find application as an effective way to stimulate biotechnological production of MnP and chitinase by white rot fungi.

1 December 2014 in Bulletin of the Veterinary Institute in Pulawy
Verified
Journal Article
Open access
PDF file
WPWojciech Jerzy Pietroń
Wojciech Jerzy Pietroń
AWAneta Woźniak
Aneta Woźniak
KPKatarzyna Pasik
Katarzyna Pasik
WCWojciech Cybulski
Wojciech Cybulski
DKDorota Krasucka
Dorota Krasucka
A liquid chromatography-ultraviolet detection method for the determination of florfenicol (FF) and thiamphenicol (TAP) in feeds is presented. The method comprises the extraction of analytes from the matrix with a mixture of methanol and acetonitrile, drying of the extract, and its dissolution in phosphate buffer. The analysis was performed with a gradient programme of the mobile phase composed of acetonitrile and buffer (pH = 7.3) on a Zorbax Eclipse Plus C18 (150 × 4.6 mm, 5 μm) analytical column with UV (λ = 220 nm) detection. The analytical procedure has been successfully adopted and validated for quantitative determination of florfenicol and thiamphenicol in feed samples. Sensitivity, specificity, linearity, repeatability, and intralaboratory reproducibility were included in the validation. The mean recovery of amphenicols was 93.5% within the working range of 50-4000 mg/kg. Simultaneous determination of chloramphenicol, which is banned in the feed, was also included within the same procedure of FF and TAP stability studies. Storing the medicated feed at room temperature for up to one month decreased concentration in the investigated drugs even by 45%. These findings are relevant to successful provision of therapy to animals.

31 May 2021 in Journal of Veterinary Research
Verified
Journal Article
Open access
KPKatarzyna Pasik
Katarzyna Pasik
KDKatarzyna Domańska-Blicharz
Katarzyna Domańska-Blicharz
The world of vaccines has changed tremendously since the time of Louis Pasteur. In the present day, it is regarded as vaccinology, a discipline which includes not only the knowledge of vaccine production, strategies for its delivery and influence on the clinical course of disease and the response of the host immune system but also regulatory, ethical, economic and ecological aspects of their use. A hundred years after Pasteur created the first vaccine, there was another scientific breakthrough of great importance in this field, i. e. Sanger sequencing. Progress in genome sequencing and other molecular techniques over the intervening 40 years has been enormous. High-throughput sequencing (HTS) platforms and bioinformatics tools are becoming widely available, falling in cost, and results are achieved very quickly. They enable the construction of modern vaccines, as well as the assessment of their safety, effectiveness and impact on the host organism and the environment. These techniques can also provide a tool for quality control of vaccines. Unprecedented possibilities are opened up by the HTS technique, but limiting factors on its implementation have to be contended with such as lack of reference materials and problems with method optimisation or validation. In the face of the current COVID-19 pandemic, a significant role is allotted to this sequencing technique while an effective vaccine against the disease caused by SARS-CoV-2 is sough.

1 June 2026 in Journal of Veterinary Research
Verified
Journal Article
Open access
PDF file
IMIlona Barbara Materek
Ilona Barbara Materek
KPKatarzyna Pasik
Katarzyna Pasik
EBEwa Borzym
Ewa Borzym
Introduction: Antimicrobial resistance (AMR) poses a global threat to public and animal health, and its progression is closely linked to the use of antimicrobials in veterinary medicine. In Europe, programmes such as the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) and subsequently European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) monitor and attempt to reduce the consumption of antimicrobials in food-producing animals. The study analyses the trends in the volume and sales structure of veterinary antimicrobials in Poland in 2011–2023 and compares them with data reported by other European countries. Material and Methods: The analysis was based on data from ESVAC reports (2011–2022) and the first ESUAvet report (2023), as well as data from the European Medicines Agency’s Antimicrobial Sales and Use Platform. The data were evaluated by antimicrobial class, pharmaceutical form and Antimicrobial Advice Ad-hoc Expert Group (AMEG) categories, the latter being A (avoid), B (restrict), C (caution) and D (prudence). Results: While total sales of veterinary antimicrobials in Europe decreased by 48.0% between 2011 and 2023, in Poland they increased by 19.5% during the same period. In Poland, the predominance of AMEG category D antimicrobials persisted, although their share declined from 79% to 64% with a concurrent increase in sales of category C. The sales structure shifted significantly towards oral solutions, replacing oral powders. Penicillins became the dominant antimicrobial group in the later years, while tetracyclines sales declined. Conclusion: The Polish trend diverges from the European one of reducing veterinary antimicrobial consumption. To align with EU reduction targets, Poland should strengthen antimicrobial stewardship, tighten prescription control and promote preventive measures such as vaccination and higher biosecurity within the One Health framework.

1 December 2019 in Journal of Veterinary Research
Verified
Journal Article
Open access
PDF file
KPKatarzyna Pasik
Katarzyna Pasik
EŁEwa Łysiak
Ewa Łysiak
Medicinal products in Europe are under the strict control of many organisations headed by the European Directorate for the Quality of Medicines and HealthCare (EDQM) in Strasbourg and its related General European Official Medicines Control Laboratories (OMCLs) Network (GEON). The EDQM works in cooperation with the European Medicines Agency (EMA) and the World Health Organisation (WHO). All of these institutions have one main goal – to protect public health in Europe and around the world. One of the more important effects of the harmonisation of pharmaceutical law in Europe was the introduction of the mutual recognition principle for the Official Control Authority Batch Release (OCABR)/Official Batch Protocol Review (OBPR) certificates in the European Union. The National Veterinary Research Institute (NVRI) in Poland is an example of an OMCL laboratory within the Veterinary Batch Release Network (VBRN) that issues the European certificates. The NVRI is actively involved in the batch release of immunological veterinary medicinal products (IVMPs), with approximately 1,800 certificates for IVMPs issued per year. It is also one of only four veterinary OMCLs that perform Post Marketing Surveillance (PMS) studies including approximately 47 IVMPs per year. All the results of the testing data are sent to the Chief Veterinary Officer, and also to the electronic Network platforms of the EDQM, which enables transparent information exchange.

1 December 2024 in Journal of Veterinary Research
Verified
Journal Article
Open access
PDF file
KPKatarzyna Pasik
Katarzyna Pasik
KDKatarzyna Domańska-Blicharz
Katarzyna Domańska-Blicharz
EIEwelina Iwan
Ewelina Iwan
ABArkadiusz Bomba
Arkadiusz Bomba
Introduction: In Europe, veterinary vaccines are strictly controlled by the Official Medicines Control Laboratories (OMCLs) of the General European OMCL Network, coordinated by the European Directorate for the Quality of Medicines & HealthCare. Despite a meticulous verification programme for immunological veterinary medicinal products (IVMPs), the products’ genomic composition has not yet been subject to evaluation in veterinary pharmacy. Material and Methods: A study was carried out on Poland’s poultry vaccines containing the infectious bronchitis virus which have the greatest market penetration. Three batches of three different vaccines were high-throughput sequenced and analysed for genomic composition, frequency of variants and the phylogeny of the strains. Results: The main genetic component of each vaccine was infectious bronchitis coronavirus. The identity of the vaccine strain types was confirmed to be consistent with the manufacturer's declaration (793B, Mass and QX). Most variants were identified for the same nucleotide positions in all three batches of each vaccine, demonstrating the homogeneity of the samples, while unique variants specific to single batches were rare. Conclusion: High-throughput sequencing (HTS) is an effective alternative poultry IVMP quality control tool for OMCLs. This technique allows in-depth characterisation of a vaccine strain and assessment of its conformance to the manufacturer’s declaration. Importantly, HTS brings new cognitive value to IVMP quality control, because it makes monitoring the level of revertants possible. However, before it could be introduced into routine quality control, a thorough analysis and characteristics of the IVMP to be evaluated is needed from the medical product’s manufacturer.